NCT00128778View on ClinicalTrials.gov

Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

288

Participants

Timeline

Start Date

October 28, 2002

Primary Completion Date

June 1, 2007

Study Completion Date

July 7, 2010

Conditions

Breast Neoplasms

Interventions

DRUG

Pegylated liposomal doxorubicin

Trial Locations (1)

28700

Spanish Breast Cancer Research Group (GEICAM), San Sebastián de los Reyes

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

Spanish Breast Cancer Research Group

OTHER